Royal Bank of Canada
PHGE icon

Royal Bank of Canada’s BiomX PHGE Stock Holding History

Royal Bank of Canada’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
+251
New +$1.18K ﹤0.01% 6925

Other funds holding PHGE

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Royal Bank of Canada's PHGE Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in BiomX (PHGE) in Q1 2026: 251 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #6925 among its holdings.

13 funds tracked by Wall St. Rank hold PHGE as of Q1 2026.

  • Royal Bank of Canada held 251 shares of BiomX worth $1K as of Q1 2026.
  • BiomX was a new Royal Bank of Canada position in Q1 2026.
  • BiomX made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6925 holding.
  • 13 funds tracked by Wall St. Rank held BiomX as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.